PROFESSIONAL EDITION

The largest community of pharma leaders

Trastuzumab Deruxtecan Recommended for Approval in the EU by CHMP for HER2 Positive Metastatic Breast Cancer

TOKYO & MUNICH–(BUSINESS WIRE)–Trastuzumab Deruxtecan Recommended for Approval in the EU by CHMP for HER2 Positive Metastatic Breast Cancer

Source Business Wire Health: Pharmaceutical NewsRead More

Recent Articles